Antidote
PrivateLast Round
Seed
Jan 21, 2026
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Antidote operates in Enterprise Software and is based in London. Its latest recorded funding round was a Seed round in January 2026.
Antidote is a legal tech company that provides an AI-powered billing compliance platform designed for law firms to automate time entry compliance, reduce revenue leakage, and streamline billing operations.
Sector
Enterprise Software
Verticals
Legal Tech, Compliance & Risk, Workflow Automation, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antidote Comparables
Compare Antidote with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PointOne | 88% | |
| Ayora Technologies | 83% | |
| Billables AI | 75% |
For institutional investors. Book with your work email.
Antidote Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Antidote Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lakestar | Seed |
| The LegalTech Fund | Seed |
| Concept Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Mar 23, 2026
Grew 33% QoQ from 9 to 12 employees.
For institutional investors. Book with your work email.
Antidote Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Antidote's valuation, stock price, and market status.
Is Antidote a public or private company?
Antidote is a private company.
What is the current stock price of Antidote?
Antidote is a private company, so its shares have no public market price. Caplight tracks Antidote's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antidote worth (valuation)?
Valuation information for Antidote is not publicly available.
Can I buy Antidote stock?
Antidote shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antidote's last funding round?
Antidote's most recent funding round was Seed on January 21, 2026.
Who are the main investors in Antidote?
Key investors in Antidote include Lakestar.
Will Antidote IPO soon?
No public IPO plans have been announced for Antidote.
How can I track Antidote secondary market activity?
Caplight tracks bids, offers, and trades in Antidote's shares on secondary markets.